Overview

Melatonin as Adjuvant Treatment for ADHD in Adults

Status:
Unknown status
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the effect of melatonin supplementation as adjuvant treatment in ADHD in adults.
Phase:
Phase 3
Details
Lead Sponsor:
Hospital Israelita Albert Einstein
Collaborators:
Fundação de Amparo à Pesquisa do Estado de São Paulo
University of Sao Paulo
Treatments:
Melatonin